Cooper Companies (COO) Announces Earnings Results
Cooper Companies (NYSE:COO) released its quarterly earnings results on Thursday. The medical device company reported $2.65 earnings per share for the quarter, topping analysts’ consensus estimates of $2.64 by $0.01, Bloomberg Earnings reports. Cooper Companies had a return on equity of 16.00% and a net margin of 16.45%. The firm had revenue of $561.50 million during the quarter, compared to the consensus estimate of $558.86 million. During the same quarter in the prior year, the firm posted $2.28 EPS. The business’s revenue was up 8.3% on a year-over-year basis. Cooper Companies updated its FY18 guidance to $11.35-11.65 EPS.
Shares of Cooper Companies (NYSE COO) opened at $238.80 on Friday. The firm has a market capitalization of $11,457.55, a PE ratio of 25.03, a P/E/G ratio of 1.95 and a beta of 0.54. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.51 and a quick ratio of 1.29. Cooper Companies has a 12 month low of $165.98 and a 12 month high of $256.39.
A number of research firms recently weighed in on COO. J P Morgan Chase & Co restated a “hold” rating and issued a $235.00 price target on shares of Cooper Companies in a research note on Tuesday, September 12th. Oppenheimer restated a “hold” rating and issued a $250.00 price target on shares of Cooper Companies in a research note on Tuesday, September 12th. Stifel Nicolaus reiterated a “buy” rating and set a $265.00 price objective (down previously from $275.00) on shares of Cooper Companies in a research report on Friday. Zacks Investment Research cut Cooper Companies from a “buy” rating to a “hold” rating in a research report on Monday, August 14th. Finally, Robert W. Baird reiterated a “buy” rating and set a $273.00 price objective (up previously from $267.00) on shares of Cooper Companies in a research report on Tuesday, September 12th. Six analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $259.70.
About Cooper Companies
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc and related companies with MarketBeat.com's FREE daily email newsletter.